About This Event

Xenon Pharmaceuticals Inc (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, visits the Nasdaq MarketSite in Times Square to celebrate its recent positive Phase 3 clinical trial results in epilepsy and progress toward becoming a commercial biopharmaceutical company.

In honor of the occasion, Ian Mortimer, President & Chief Executive Officer, rings the Opening Bell.